32 Biosciences vs Caris Life Sciences
32 Biosciences vs Caris Life Sciences, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 32 Biosciences is on 42/100 and Caris Life Sciences on 59/100.
Where each one leads
32 Biosciences
Leads on none of the measures we hold for both companies.
Caris Life Sciences
- our overall score: 59/100 against 42/100
- agent readiness: 47/100 against 21/100
- domain rating: 63/100 against 13/100
- headcount: 1,659 against 9
- funding raised: $700M against $12.0M
- LinkedIn following: 77,698 against 926
At a glance
| Measure | 32 Biosciences | Caris Life Sciences |
|---|---|---|
| What it is | Develops novel therapeutic antibodies for oncology and autoimmune diseases. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, Drug Discovery, Oncology, Autoimmune Diseases | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2017 | 2008 |
| Headquarters | San Diego, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | 32 Biosciences | Caris Life Sciences |
|---|---|---|
| Employees | 9 | 1,659 |
| Total funding | $12.0M | $700M |
| Latest round | Not published | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | 926 | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 32 Biosciences | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 59/100 |
| Traction | 45/100 | 60/100 |
| Team | 30/100 | Not published |
| Community | 3/100 | Not published |
| Search visibility | 24/100 | 22/100 |
| Quality | 48/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 32 Biosciences | Caris Life Sciences |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Tag Manager |
What users say
| Measure | 32 Biosciences | Caris Life Sciences |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 1.0/5 from 1 vote | Not published |
32 Biosciences vs Caris Life Sciences: common questions
Which is better, 32 Biosciences or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do 32 Biosciences and Caris Life Sciences compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 42/100), agent readiness (47/100 against 21/100), domain rating (63/100 against 13/100), headcount (1,659 against 9), funding raised ($700M against $12.0M), LinkedIn following (77,698 against 926).
Read the full 32 Biosciences review and pricing or the Caris Life Sciences review and pricing. You can also browse other 32 Biosciences alternatives we track.